FDA Issues Warning Letter To Company Selling CBD Products With Unproven Health Claims

The U.S. Food and Drug Administration (FDA) has sent a warning letter to Curaleaf, a company that markets cannabidiol-based products using “unsubstantiated” health claims. Continue Reading →

FDA Taking Steps To Lower Generic Drug Prices From Harlem To Hollywood

When he served as commissioner of the Food and Drug Administration (FDA), Dr. Scott Gottlieb pressed for lower prescription drug prices by speeding development of generic alternatives. Continue Reading →

Sign Up for the Harlem World Newsletter